Skip to content
52
For organizationsPricingSign in

Connections

SB 521

9 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.

Start with
and connect to
Sponsors
Steve BradfordCalifornia lawmaker · D

SB 521

Drug manufacturers: value-based arrangement

California · Committee hearing

Open page
Lobbied on it8 of 15
bluebird bio, Inc.7 reportsAbbvie3 reportsBiogen Ma Inc.3 reportsBiotechnology Innovation Organization3 reportsVertex Pharmaceuticals Inc.3 reportsViatris Inc.3 reportsAlexion Pharmaceuticals, Inc.2 reportsAstrazeneca Pharmaceuticals, LP2 reports
SB 521: the one sponsors and 8 of 15 groups that lobbied on it. Point at anyone to see how they are linked.

Every link on this map

The same connections as a table, with the reason each one is here.

Connections of SB 521
Steve BradfordSponsorsSteve Bradford sponsored SB 521.None
bluebird bio, Inc.Lobbied on itbluebird bio, Inc. named SB 521 in 7 lobbying reports.7 reports
AbbvieLobbied on itAbbvie named SB 521 in 3 lobbying reports.3 reports
Biogen Ma Inc.Lobbied on itBiogen Ma Inc. named SB 521 in 3 lobbying reports.3 reports
Biotechnology Innovation OrganizationLobbied on itBiotechnology Innovation Organization named SB 521 in 3 lobbying reports.3 reports
Vertex Pharmaceuticals Inc.Lobbied on itVertex Pharmaceuticals Inc. named SB 521 in 3 lobbying reports.3 reports
Viatris Inc.Lobbied on itViatris Inc. named SB 521 in 3 lobbying reports.3 reports
Alexion Pharmaceuticals, Inc.Lobbied on itAlexion Pharmaceuticals, Inc. named SB 521 in 2 lobbying reports.2 reports
Astrazeneca Pharmaceuticals, LPLobbied on itAstrazeneca Pharmaceuticals, LP named SB 521 in 2 lobbying reports.2 reports